There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Equipment and Processing Report talked to Jonathan Seville, dean of the School of Engineering at the University of Warwick, to find out how positron-emission particle tracking could help pharmaceutical manufacturers gain process understanding.

Positron-Emission Particle Tracking Could Demystify Mixing

Company and People Notes: GlaxoSmithKline acquires Nanjing MeiRui Pharma; Cephalon's CEO to remain on medical leave; and more.

Week of Dec. 6, 2010: Company and People Notes: GlaxoSmithKline Acquires Nanjing MeiRui Pharma; Cephalon's CEO to Remain on Medical Leave; and More.

Genzyme Sells Business Unit to Sekisui Chemical; Ablexis Names VP of Research; and More.

Week of Nov. 22, 2010: Company and People Notes: Genzyme Sells Business Unit to Sekisui Chemical; Ablexis Names VP of Research; and More.

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The International Conference on Harmonization (ICH) Steering Committee (SC) and its working groups met in Fukuoka, Japan Nov. 6-11, 2010.

ICH Meets in Japan

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

European confidence and optimism in biotechnology is increasing, according to a survey conducted by the European Commission.

Survey Shows Europe's Perception of Biotechnology to be Favorable

The European Medicines Agency and the Massachusetts Institute of Technology's (MIT's) Center for Biomedical Innovation (CBI) and Center for International Studies (CIS) are launching a collaborative research project with a focus on enhancing regulatory science in pharmaceuticals, according to an EMA press release.

EMA, MIT Form Research Project for Regulatory Science

During the 20 months before the crisis of contaminated heparin in early 2008, the US Food and Drug Administration did not inspect any Chinese heparin firms, according to a US Government Accountability Office, (GAO) report.

GAO Evaluates FDA's Response to 2008 Heparin Crisis

Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

Week of Nov. 15, 2010: Company and People Notes: Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

The biotechnology company Biogen Idec (Weston, MA) announced last week a major restructuring program that will refocus the company's research and development (R&D) programs, consolidate facilities, and reduce its workforce.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes